Background Worldwide, hepatocellular carcinoma (HCC) is a universal problem and its
epidemiological data showed variation from place to place. Hepatocellular carcinoma (HCC) …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Hepatocellular carcinoma is the second most common cause of cancer death in the world
and its incidence has dramatically increased worldwide in the past two decades. Syringic …

Primary liver cancer is a challenging global health concern with an estimated more than a
million persons to be affected annually by the year 2025. The commonest type is …

Microbes have long been used for the synthesis of a variety of nanoparticles. Hepatocellular
carcinoma (HCC) is the primary liver cancer and it is the second leading cause of cancer …

Next-generation sequencing has uncovered thousands of long noncoding RNAs (lncRNA).
Many are reported to be aberrantly expressed in various cancers, including hepatocellular …

Background Hepatocellular carcinoma (HCC) is the most common type of liver cancer.
CircFUT8 has been shown to be upregulated in cancers, but its function in HCC remains …

Background Chronic diseases are a major cause of mortality worldwide, and despite the
recent development in treatment modalities, synthetic drugs have continued to show toxic …

Background Immunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but
reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular …

Abstract Multiple three-dimensional (3D) tumour organoid models assisted by multi-omics
and Artificial Intelligence (AI) have contributed greatly to preclinical drug development and …